Literature DB >> 33796278

Clash of the pandemics - At least 150'000 adults in Switzerland suffer from obesity grades 2 or 3 and are thus at elevated risk for severe COVID-19.

Kaspar Staub1,2,3, Katarina L Matthes1, Frank Rühli1,2,3, Nicole Bender1,3.   

Abstract

Background: Grade 2 and 3 obesity, alongside with other relevant risk factors, are substantially and independently associated with adverse outcomes of coronavirus disease 2019 (COVID-19). However, for Switzerland, due to the lack of synthesis studies, it is currently unknown how many people are affected by obesity at all. This knowledge may help to better estimate the relevance and size of this group at elevated risk, which could be incorporated into strategies to protect risk groups during the still unfolding COVID-19 pandemic. This study aimed to provide a first overall estimation of how many people in Switzerland are currently affected by grade 2 or 3 obesity.
Methods: Five representative national population-based studies were accessed which were conducted between 2012 and 2017 and which include data on height and weight of adult men and women in Switzerland.
Results: In Switzerland in 2012-2017, among the 11.20% adults who were obese (body mass index (BMI) ≥30.0kg/m2), 1.76% (95% CI 1.50-2.02) suffered from grade 2 obesity (BMI 35.0-39.9 kg/m2), and 0.58% (95% CI 0.50-0.66) from grade severe 3 obesity (BMI ≥40.0 kg/m2). Converted into estimated absolute population numbers, this corresponds to a total of approximately n=154,515 people who suffer from grade 2 or 3 obesity (n=116,216 and n=38,298, respectively). Conclusions: This risk group includes many younger people in Switzerland. The number of people with obesity-related risk becomes 3.8 to 13.6 times higher if grade 1 obesity and overweight people are also included in this risk group, for which there are arguments arising in the latest literature. In general, this large group at risk for severe COVID-19 should be given more attention and support. If it is confirmed that obesity plays a major role in severe COVID-19 courses, then every kilo of body weight that is not gained or that is lost in lockdown counts. Copyright:
© 2020 Staub K et al.

Entities:  

Keywords:  Adiposity; NCD; Public Health; Risk groups; Sars-Cov-2

Mesh:

Year:  2020        PMID: 33796278      PMCID: PMC7970431          DOI: 10.12688/f1000research.27819.1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  28 in total

1.  Variation in mortality patterns among the general population, study participants, and different types of nonparticipants: evidence from 25 years of follow-up.

Authors:  Matthias Bopp; Julia Braun; David Faeh
Journal:  Am J Epidemiol       Date:  2014-10-24       Impact factor: 4.897

2.  Obesity, inflammation and COVID-19.

Authors:  Alberto Beretta
Journal:  Swiss Med Wkly       Date:  2020-08-19       Impact factor: 2.193

3.  Obesity in Switzerland: do estimates depend on how body mass index has been assessed?

Authors:  David Faeh; Pedro Marques-Vidal; Arnaud Chiolero; Matthias Bopp
Journal:  Swiss Med Wkly       Date:  2008-04-05       Impact factor: 2.193

4.  European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic.

Authors:  Gema Frühbeck; Jennifer Lyn Baker; Luca Busetto; Dror Dicker; Gijs H Goossens; Jason C G Halford; Teodora Handjieva-Darlenska; Maria Hassapidou; Jens-Christian Holm; Susanna Lehtinen-Jacks; Dana Mullerova; Grace O'Malley; Jørn V Sagen; Harry Rutter; Ximena Ramos Salas; Euan Woodward; Volkan Yumuk; Nathalie J Farpour-Lambert
Journal:  Obes Facts       Date:  2020-04-27       Impact factor: 3.942

5.  Increasing variability of body mass and health correlates in Swiss conscripts, a possible role of relaxed natural selection?

Authors:  Kaspar Staub; Maciej Henneberg; Francesco M Galassi; Patrick Eppenberger; Martin Haeusler; Irina Morozova; Frank J Rühli; Nicole Bender
Journal:  Evol Med Public Health       Date:  2018-04-28

6.  The impact of obesity on COVID-19 complications: a retrospective cohort study.

Authors:  Mohamed Nakeshbandi; Rohan Maini; Pia Daniel; Sabrina Rosengarten; Priyanka Parmar; Clara Wilson; Julie Minjae Kim; Alvin Oommen; Max Mecklenburg; Jerome Salvani; Michael A Joseph; Igal Breitman
Journal:  Int J Obes (Lond)       Date:  2020-07-25       Impact factor: 5.095

7.  COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity.

Authors:  Saverio Cinti; Laura Graciotti; Antonio Giordano; Alessandra Valerio; Enzo Nisoli
Journal:  Int J Obes (Lond)       Date:  2020-06-08       Impact factor: 5.095

8.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

9.  Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS-CoV-2.

Authors:  Yang Yang; Lin Ding; Xianlun Zou; Yaqi Shen; Daoyu Hu; Xuemei Hu; Zhen Li; Ihab R Kamel
Journal:  Obesity (Silver Spring)       Date:  2020-09-17       Impact factor: 9.298

10.  Is Growth Hormone Insufficiency the Missing Link Between Obesity, Male Gender, Age, and COVID-19 Severity?

Authors:  Carla Lubrano; Davide Masi; Renata Risi; Angela Balena; Mikiko Watanabe; Stefania Mariani; Lucio Gnessi
Journal:  Obesity (Silver Spring)       Date:  2020-09-25       Impact factor: 9.298

View more
  1 in total

1.  Body mass index in young men in Switzerland after the national shutdowns during the COVID-19 pandemic: Results from a cross-sectional monitoring study at the population level since 2010.

Authors:  Samuel Meili; Marek Brabec; Frank Rühli; Thomas W Buehrer; Nejla Gültekin; Zeno Stanga; Nicole Bender; Kaspar Staub; Emilie Reber
Journal:  Eur J Public Health       Date:  2022-08-22       Impact factor: 4.424

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.